Related Experiment Video
Updated: May 11, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Impact of COVID-19 on preexisting comorbidities
Rasha Ashmawy1, Esraa Abdellatif Hamouda1, Sally Zeina1
1Ministry of Health and Population, Alexandria, Egypt.
Insights
This study analyzes how common health conditions, known as comorbidities, impact COVID-19 outcomes. Understanding these risks is crucial for managing the pandemic and protecting vulnerable populations.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- COVID-19 (Coronavirus Disease 2019) emerged as a significant global health crisis in 2020.
- SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection led to a pandemic, becoming the third leading cause of death in the USA in 2020.
- Preexisting health conditions, or comorbidities, are known to increase mortality risk.
Purpose of the Study:
- To delineate and analyze the primary comorbidities associated with COVID-19.
- To examine the repercussions of these comorbidities on individuals infected with SARS-CoV-2.
Main Methods:
- Literature review and analysis of epidemiological data.
- Identification and categorization of prevalent comorbidities.
- Assessment of the impact of comorbidities on COVID-19 severity and outcomes.
Main Results:
- Hypertension, diabetes, respiratory diseases, and cardiovascular diseases were identified as paramount comorbidities.
- These conditions significantly increase the risk of severe illness and death in COVID-19 patients.
- Analysis highlights the disproportionate impact on elderly individuals and those with multiple comorbidities.
Conclusions:
- Comorbidities represent a critical factor in COVID-19 prognosis.
- Public health strategies should prioritize individuals with these underlying conditions.
- Further research is needed to understand the complex interplay between comorbidities and SARS-CoV-2 infection.
Abstract:
COVID-19 is a highly contagious viral disease caused by SARS-CoV-2, leading to a tragic global pandemic, where it was ranked in 2020 as the third leading cause of death in the USA, causing approximately 375,000 deaths, following heart disease and cancer. The CDC reports that the risk of death increases with age and preexisting comorbidities such as such as hypertension, diabetes, respiratory system disease, and cardiovascular disease. this report will delineate and analyze the paramount comorbidities and their repercussions on individuals infected with SARS-CoV-2.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation